Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors (Micro3)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06046144 |
Recruitment Status :
Completed
First Posted : September 21, 2023
Last Update Posted : September 21, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Reflectance confocal microscopy (RCM) is the reference in vivo imaging technique for identifying malignant melanocytic tumors prior to surgical excision. However, it is not widely used due to its high cost and highly technical and time-consuming nature.
In addition to RCM, we currently use 2 less expensive dermatoscopes that also allow in vivo diagnosis: super-high magnification dermoscopy (D400) and Fluorescence-Advanced videodermatoscopy (FAV).
Condition or disease | Intervention/treatment |
---|---|
Basal Cell Carcinoma Lentigo Maligna Melanoma Nevus Seborrheic Keratosis Lentigo | Diagnostic Test: Fluorescence-Advanced videodermatoscopy Diagnostic Test: Reflectance confocal microscopy Diagnostic Test: Super-high magnification dermoscopy |
Several studies have demonstrated their interest in the in vivo diagnosis of melanocytic tumors, but without any comparison between these methods.
In our current practice, many patients have benefited from these 3 imaging modalities for benign and malignant lesions.
Therefore, our aim is to analyze these images and compare their performance in the diagnosis of benign and malignant pigmented lesions.
Study Type : | Observational |
Actual Enrollment : | 161 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors. Monocentric Retrospective Study of 170 Tumors |
Actual Study Start Date : | November 2, 2022 |
Actual Primary Completion Date : | May 1, 2023 |
Actual Study Completion Date : | May 1, 2023 |
Group/Cohort | Intervention/treatment |
---|---|
Patients with a pigmented skin lesion
Patients with a pigmented skin lesion of more than 3mm diameter which have benefited systematically of all 3 imaging techniques at the same time, followed by either a surgical excision or annual imaging monitoring.
|
Diagnostic Test: Fluorescence-Advanced videodermatoscopy
Datas collected : Presence or absence of atypical roundish cell, dendritic cell, atypical nests, points, folliculotropism, blue homogenous zone, regular honeycomb pattern. Between 10 and 60 images taken by a hand-held camera set directly on the skin lesion, with an oily interface. Diagnostic Test: Reflectance confocal microscopy Datas collected : Presence or absence of atypical roundish cell, dendritic cell, atypical nests, points, folliculotropism, blue homogenous zone, regular honeycomb pattern. Between 10 and 60 images taken by a hand-held camera set directly on the skin lesion, with an oily interface. Diagnostic Test: Super-high magnification dermoscopy Datas collected : Presence or absence of atypical roundish cell, dendritic cell, atypical nests, points, folliculotropism, blue homogenous zone, regular honeycomb pattern. Between 10 and 60 images taken by a hand-held camera set directly on the skin lesion, with an oily interface. |
- To analyse the picture to assess the relevance of each technique for the diagnostic of malignant and benign pigmented lesions. [ Time Frame: Day 1 ]
The nature of the tumor is diagnosed by an imaging technique if we can find on the images the main characteristics belonging to a certain tumor.
After this we can calculate the sensitivity, specificity of each technique.
- Comparison of different imaging techniques [ Time Frame: Day 1 ]To compare the performance of combination of 2 techniques to assess if the performance is better than 1 technique alone.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients with a pigmented skin lesion of more than 3mm diameter which have benefited systematically of all 3 imaging techniques at the same time, followed by either a surgical excision or annual imaging monitoring.
Exclusion Criteria:
- Bad quality images
- Insufficient number of images
- Uncertain diagnosis given by the pathologist
- Refusal
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06046144
France | |
Chu de Saint Etienne | |
Saint Etienne, France, 42000 |
Principal Investigator: | Jean-Luc PERROT, MD PhD | CHU Saint-Etienne |
Responsible Party: | Centre Hospitalier Universitaire de Saint Etienne |
ClinicalTrials.gov Identifier: | NCT06046144 |
Other Study ID Numbers: |
IRBN1142023/CHUSTE |
First Posted: | September 21, 2023 Key Record Dates |
Last Update Posted: | September 21, 2023 |
Last Verified: | August 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Melanoma diagnosis Diagnosis Imaging Fluorescence-Advanced videodermatoscopy Reflectance confocal microscopy Super-high magnification dermoscopy |
Melanoma Carcinoma, Basal Cell Hutchinson's Melanotic Freckle Keratosis Lentigo Keratosis, Seborrheic Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms |
Neoplasms, Nerve Tissue Nevi and Melanomas Skin Neoplasms Neoplasms by Site Skin Diseases Carcinoma Neoplasms, Glandular and Epithelial Neoplasms, Basal Cell Melanosis Hyperpigmentation Pigmentation Disorders |